Steven V. Manoukian, MD

Hexabrix (Ioxaglate) and Factors for Contrast Media Selection
06/14/2010
Hexabrix is an ionic, low-osmolar, low-viscosity contrast media. It has been shown to contain anti-thrombogenic properties. Dr. Manoukian shares his experience and discusses current thinking in this area. What properties are important when...
Hexabrix is an ionic, low-osmolar, low-viscosity contrast media. It has been shown to contain anti-thrombogenic properties. Dr. Manoukian shares his experience and discusses current thinking in this area. What properties are important when...
Hexabrix is an ionic,...
06/14/2010
Cath Lab Digest
Review
The Relationship Between Bleeding and Adverse Outcomes in ACS and PCI: Pharmacologic and Nonpharmacologic Modification of Risk
03/03/2010
ABSTRACT: Antithrombotic therapy, including antiplatelet and antithrombin agents, effectively reduces the risk of ischemic events in patients with acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI)....
ABSTRACT: Antithrombotic therapy, including antiplatelet and antithrombin agents, effectively reduces the risk of ischemic events in patients with acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI)....
ABSTRACT: Antithrombotic...
03/03/2010
Journal of Invasive Cardiology

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use